Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells

Oncotarget

Volumn 6, Issue 1, 2015, Pages 71-84

  Desiderio, Vincenzo ^a,c,d   Papagerakis, Petros ^a,b,d   Tirino, Virginia ^c,d   Zheng, Li ^b,d   Matossian, Margarite ^a,d   Prince, Mark E ^a,d   Paino, Francesca ^c,d   Mele, Luigi ^a,c,d   Papaccio, Federica ^c,d   Montella, Roberta ^c,d   Papaccio, Gianpaolo ^c,d   Papagerakis, Silvana ^a,b,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cancer stem cells; Cisplatin; Fucosylation; Oral cancer; Radiation

Indexed keywords

ALDEHYDE DEHYDROGENASE; BETA1 INTEGRIN; CD56 ANTIGEN; CISPLATIN; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 3; FUCOSYLTRANSFERASE 6; POLYSACCHARIDE; UNCLASSIFIED DRUG; 5-ACETYLNEURAMINYL-(2-3)-GALACTOSYL-(1-4)-(FUCOPYRANOSYL-(1-3))-N-ACETYLGLUCOSAMINE; ANTINEOPLASTIC AGENT; FUCOSE; OLIGOSACCHARIDE; TUMOR MARKER;

ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STEM CELL; CARCINOGENICITY; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; CULTURE TECHNIQUE; CYTOMETRY; DISTANT METASTASIS; FUCOSYLATION; HEAD AND NECK CANCER; HUMAN; IN VIVO STUDY; METASTASIS; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; SHEAR FLOW; TUMOR INVASION; UPREGULATION; ANIMAL; CANCER TRANSPLANTATION; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG RESISTANCE; FEMALE; HEAD AND NECK NEOPLASMS; MECHANICAL STRESS; METABOLISM; MOUSE; NEOPLASM; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; SHEAR STRENGTH;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOMARKERS, TUMOR; CELL ADHESION; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; FEMALE; FUCOSE; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOPLASTIC STEM CELLS; OLIGOSACCHARIDES; SHEAR STRENGTH; STRESS, MECHANICAL;

EID: 84921368043     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2698     Document Type: Article

References (70)

1. Scully C and Bagan J. Oral squamous cell carcinoma overview. Oral oncology. 2009; 45(4-5):301-308.
2. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral oncology. 2009; 45(4-5):309-316.
3. Zhang P, Zhang Y, Mao L, Zhang Z and Chen W. Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer letters. 2009; 277(2):227-234.
4. Kelly C, Paleri V, Downs C and Shah R. Deterioration in quality of life and depressive symptoms during radiation therapy for head and neck cancer. Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2007; 136(1):108-111.
5. Rogers SN, Ahad SA and Murphy AP. A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000-2005. Oral oncology. 2007; 43(9):843-868.
6. Liebertz DJ, Lechner MG, Masood R, Sinha UK, Han J, Puri RK, Correa AJ and Epstein AL. Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1. Head & neck oncology. 2010; 2:5.
7. McCullough MJ, Prasad G and Farah CS. Oral mucosal malignancy and potentially malignant lesions: an update on the epidemiology, risk factors, diagnosis and management. Australian dental journal. 2010; 55 Suppl 1:61-65.
8. Choi S and Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. Journal of dental research. 2008; 87(1):14-32.
9. Parkin DM, Bray F, Ferlay J and Pisani P. Global cancer statistics, 2002. CA: a cancer journal for clinicians. 2005; 55(2):74-108.
10. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer research. 2006; 66(19):9339-9344.
11. Ward RJ and Dirks PB. Cancer stem cells: at the headwaters of tumor development. Annual review of pathology. 2007; 2:175-189.
12. Dewan MZ, Ahmed S, Iwasaki Y, Ohba K, Toi M and Yamamoto N. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2006; 60(6):273-276.
13. Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, La Noce M, Laino L, De Francesco F and Papaccio G. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2013; 27(1):13-24.
14. Desiderio V, Paino F, Nebbioso A, Altucci L, Pirozzi G, Papaccio F, La Noce M, De Rosa A, Papaccio G and Tirino V. Molecular Profiling of Human Primary Chondrosarcoma-Derived Spheres Reveals Specific and Target Genes Involved in Multidrug Resistance and Metastasis. Journal of Carcinogenesis & Mutagenesis. 2013; 5(1).
15. Tirino V, Desiderio V, Paino F, Papaccio G and De Rosa M. Methods for cancer stem cell detection and isolation. Methods in molecular biology. 2012; 879:513-529.
16. Rappa G, Mercapide J, Anzanello F, Prasmickaite L, Xi Y, Ju J, Fodstad O and Lorico A. Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Experimental cell research. 2008; 314(10):2110-2122.
17. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100(7):3983-3988.
18. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT and Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005; 121(6):823-835.
19. O'Brien CA, Pollett A, Gallinger S and Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007; 445(7123):106-110.
20. Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer research. 2005; 65(23):10946-10951.
21. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT and Donahoe PK. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proceedings of the National Academy of Sciences of the United States of America. 2006; 103(30):11154-11159.
22. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F and Vescovi AL. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006; 444(7120):761-765.
23. Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, Fazioli F, Pirozzi G and Papaccio G. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2011; 25(6):2022-2030.
24. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles LE. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(3):973-978.
25. Marques ETA, Jr. (2000). Fucosyltransferases In: Ernst B, Hart, G. W., Sinay, P, ed. Carbohydrate in Chemistry and Biology. (Weinheim: Wiley-VCH), pp. 197-211.
26. Clarke JL and Watkins W. Alpha1,3-L-fucosyltransferase expression in developing human myeloid cells. Antigenic, enzymatic, and mRNA analyses. The Journal of biological chemistry. 1996; 271(17):10317-10328.
27. Wiederschain GY, Koul O, Aucoin JM, Smith FI and McCluer RH. alpha1,3 Fucosyltransferase, alpha-Lfucosidase, alpha-D-galactosidase, beta-D-galactosidase, and Le(x) glycoconjugates in developing rat brain. Glycoconjugate journal. 1998; 15(4):379-388.
28. Blander JM, Visintin I, Janeway CA, Jr. and Medzhitov R. Alpha(1,3)-fucosyltransferase VII and alpha(2,3)-sialyltransferase IV are up-regulated in activated CD4 T cells and maintained after their differentiation into Th1 and migration into inflammatory sites. Journal of immunology. 1999; 163(7):3746-3752.
29. Lowe JB. Selectin ligands, leukocyte trafficking, and fucosyltransferase genes. Kidney international. 1997; 51(5):1418-1426.
30. Chandrasekaran EV, Xue J, Piskorz C, Locke RD, Toth K, Slocum HK and Matta KL. Potential tumor markers for human gastric cancer: an elevation of glycan:sulfotransferases and a concomitant loss of alpha1,2-fucosyltransferase activities. Journal of cancer research and clinical oncology. 2007; 133(9):599-611.
31. Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JC and Gershoni-Baruch R. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. The New England journal of medicine. 1992; 327(25):1789-1792.
32. Fukuda T, Hashimoto H, Okayasu N, Kameyama A, Onogi H, Nakagawasai O, Nakazawa T, Kurosawa T, Hao Y, Isaji T, Tadano T, Narimatsu H, Taniguchi N and Gu J. Alpha1,6-fucosyltransferase-deficient mice exhibit multiple behavioral abnormalities associated with a schizophrenialike phenotype: importance of the balance between the dopamine and serotonin systems. The Journal of biological chemistry. 2011; 286(21):18434-18443.
33. McGovern DP, Jones MR, Taylor KD, Marciante K, Yan X, Dubinsky M, Ippoliti A, Vasiliauskas E, Berel D, Derkowski C, Dutridge D, Fleshner P, Shih DQ, Melmed G, Mengesha E, King L, et al. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Human molecular genetics. 2010; 19(17):3468-3476.
34. de Vries T, Knegtel RM, Holmes EH and Macher BA. Fucosyltransferases: structure/function studies. Glycobiology. 2001; 11(10):119R-128R.
35. Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, Wicha MS and Prince ME. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head & neck. 2010; 32(9):1195-1201.
36. Medema JP. Cancer stem cells: the challenges ahead. Nature cell biology. 2013; 15(4):338-344.
37. Owens GC, Orr EA, DeMasters BK, Muschel RJ, Berens ME and Kruse CA. Overexpression of a transmembrane isoform of neural cell adhesion molecule alters the invasiveness of rat CNS-1 glioma. Cancer research. 1998; 58(9):2020-2028.
38. Tsuchiya A, Kamimura H, Tamura Y, Takamura M, Yamagiwa S, Suda T, Nomoto M and Aoyagi Y. Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM. Cancer letters. 2011; 309(1):95-103.
39. Yang AH, Chen JY, Lee CH and Chen JY. Expression of NCAM and OCIAD1 in well-differentiated thyroid carcinoma: correlation with the risk of distant metastasis. Journal of clinical pathology. 2012; 65(3):206-212.
40. Romanini J, Mielcke TR, Leal PC, Figueiredo CP, Calixto JB, Morrone FB, Batista EL, Jr. and Campos MM. The role of CXCR2 chemokine receptors in the oral squamous cell carcinoma. Investigational new drugs. 2012; 30(4):1371-1378.
41. Justilien V, Regala RP, Tseng IC, Walsh MP, Batra J, Radisky ES, Murray NR and Fields AP. Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential. PloS one. 2012; 7(4):e35040.
42. Nolan ME, Aranda V, Lee S, Lakshmi B, Basu S, Allred DC and Muthuswamy SK. The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer. Cancer research. 2008; 68(20):8201-8209.
43. Giotakis I, Chrysovergis A, Georgolios A, Giotakis E and Manolopoulos L. Adhesion molecules in cancer of the head and neck: role of dysadherin. Journal of BUON: official journal of the Balkan Union of Oncology. 2011; 16(4):609-612.
44. Lim YC, Oh SY, Cha YY, Kim SH, Jin X and Kim H. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral oncology. 2011; 47(2):83-91.
45. Krishnamurthy S and Nor JE. Orosphere assay: a method for propagation of head and neck cancer stem cells. Head & neck. 2013; 35(7):1015-1021.
46. Wang X, Chen J, Li QK, Peskoe SB, Zhang B, Choi C, Platz EA and Zhang H. Overexpression of alpha (1,6) fucosyltransferase associated with aggressive prostate cancer. Glycobiology. 2014.
47. Li J, Guillebon AD, Hsu JW, Barthel SR, Dimitroff CJ, Lee YF and King MR. Human fucosyltransferase 6 enables prostate cancer metastasis to bone. British journal of cancer. 2013; 109(12):3014-3022.
48. Barthel SR, Gavino JD, Wiese GK, Jaynes JM, Siddiqui J and Dimitroff CJ. Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin. Glycobiology. 2008; 18(10):806-817.
49. Okeley NM, Alley SC, Anderson ME, Boursalian TE, Burke PJ, Emmerton KM, Jeffrey SC, Klussman K, Law CL, Sussman D, Toki BE, Westendorf L, Zeng W, Zhang X, Benjamin DR and Senter PD. Development of orally active inhibitors of protein and cellular fucosylation. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110(14):5404-5409.
50. Yin X, Rana K, Ponmudi V and King MR. Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion. Carbohydrate research. 2010; 345(16):2334-2342.
51. Prince ME and Ailles LE. Cancer stem cells in head and neck squamous cell cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2008; 26(17):2871-2875.
52. Mack B and Gires O. CD44s and CD44v6 expression in head and neck epithelia. PloS one. 2008; 3(10):e3360.
53. Davis SJ, Divi V, Owen JH, Bradford CR, Carey TE, Papagerakis S and Prince ME. Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma. Archives of otolaryngology--head & neck surgery. 2010; 136(12):1260-1266.
54. Wang SJ, Wong G, de Heer AM, Xia W and Bourguignon LY. CD44 variant isoforms in head and neck squamous cell carcinoma progression. The Laryngoscope. 2009; 119(8):1518-1530.
55. Cojoc M, Mabert K, Muders MH and Dubrovska A. A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms. Seminars in cancer biology. 2014.
56. Springer TA and Lasky LA. Cell adhesion. Sticky sugars for selectins. Nature. 1991; 349(6306):196-197.
57. Czerwinski MJ, Desiderio V, Shkeir O, Papagerakis P, Lapadatescu MC, Owen JH, Athanassiou-Papaefthymiou M, Zheng L, Papaccio G, Prince ME and Papagerakis S. In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells. Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2013; 149(1):97-104.
58. Nakagoe T, Fukushima K, Nanashima A, Sawai T, Tsuji T, Jibiki M, Yamaguchi H, Yasutake T, Ayabe H, Matuo T, Tagawa Y and Arisawa K. Expression of Lewis(a), sialyl Lewis(a), Lewis(x) and sialyl Lewis(x) antigens as prognostic factors in patients with colorectal cancer. Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 2000; 14(9):753-760.
59. Portela SV, Martin CV, Romay LM, Cuevas E, Martin EG and Briera AF. sLea and sLex expression in colorectal cancer: implications for tumourigenesis and disease prognosis. Histology and histopathology. 2011; 26(10):1305-1316.
60. St Hill CA, Baharo-Hassan D and Farooqui M. C2-O-sLeX glycoproteins are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells. PloS one. 2011; 6(1):e16281.
61. Yu CJ, Shih JY, Lee YC, Shun CT, Yuan A and Yang PC. Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer. Lung Cancer. 2005; 47(1):59-67.
62. Carvalho AS, Harduin-Lepers A, Magalhaes A, Machado E, Mendes N, Costa LT, Matthiesen R, Almeida R, Costa J and Reis CA. Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. The international journal of biochemistry & cell biology. 2010; 42(1):80-89.
63. Higai K, Miyazaki N, Azuma Y and Matsumoto K. Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene. FEBS letters. 2006; 580(26):6069-6075.
64. Padro M, Cobler L, Garrido M and de Bolos C. Downregulation of FUT3 and FUT5 by shRNA alters Lewis antigens expression and reduces the adhesion capacities of gastric cancer cells. Biochimica et biophysica acta. 2011; 1810(12):1141-1149.
65. Trinchera M, Malagolini N, Chiricolo M, Santini D, Minni F, Caretti A and Dall'olio F. The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach. The international journal of biochemistry & cell biology. 2011; 43(1):130-139.
66. Julien S, Ivetic A, Grigoriadis A, QiZe D, Burford B, Sproviero D, Picco G, Gillett C, Papp SL, Schaffer L, Tutt A, Taylor-Papadimitriou J, Pinder SE and Burchell JM. Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. Cancer research. 2011; 71(24):7683-7693.
67. Rillahan CD, Antonopoulos A, Lefort CT, Sonon R, Azadi P, Ley K, Dell A, Haslam SM and Paulson JC. Global metabolic inhibitors of sialyl-and fucosyltransferases remodel the glycome. Nature chemical biology. 2012; 8(7):661-668.
68. Cheng L, Luo S, Jin C, Ma H, Zhou H and Jia L. FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway. Cell death & disease. 2013; 4:e923.
69. Carey TE. (1999). Head and neck cancers. In: Masters J and Pallson B, eds. Human Cell Culture Kluver Accademic Publisher).
70. Owen JH, Hauff SJ, Tang AL, Graham MP, Czerwinski MJ, Kaddoura M, Papagerakis S, Bradford CR, Carey TE and Prince ME. UM-SCC-103: A Unique Tongue Cancer Cell Line That Recapitulates the Tumorigenic Stem Cell Population of the Primary Tumor. The Annals of otology, rhinology, and laryngology. 2014.